Maxcyte (MXCT) Shares Outstanding (2020 - 2025)
Historic Shares Outstanding for Maxcyte (MXCT) over the last 6 years, with Q3 2025 value amounting to $106.6 million.
- Maxcyte's Shares Outstanding rose 127.63% to $106.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $106.6 million, marking a year-over-year increase of 127.63%. This contributed to the annual value of $105.7 million for FY2024, which is 168.28% up from last year.
- Maxcyte's Shares Outstanding amounted to $106.6 million in Q3 2025, which was up 127.63% from $106.6 million recorded in Q2 2025.
- Maxcyte's 5-year Shares Outstanding high stood at $106.6 million for Q3 2025, and its period low was $84.7 million during Q2 2021.
- Moreover, its 5-year median value for Shares Outstanding was $103.3 million (2023), whereas its average is $102.6 million.
- In the last 5 years, Maxcyte's Shares Outstanding skyrocketed by 3078.25% in 2021 and then surged by 118.1% in 2022.
- Over the past 5 years, Maxcyte's Shares Outstanding (Quarter) stood at $101.2 million in 2021, then rose by 1.18% to $102.4 million in 2022, then increased by 1.53% to $104.0 million in 2023, then grew by 1.68% to $105.7 million in 2024, then increased by 0.88% to $106.6 million in 2025.
- Its Shares Outstanding stands at $106.6 million for Q3 2025, versus $106.6 million for Q2 2025 and $106.3 million for Q1 2025.